Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Nutraceuticals Market 

5.1. COVID-19 Landscape: U.S. Nutraceuticals Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. Nutraceuticals Market, By Type

8.1. U.S. Nutraceuticals Market Revenue and Volume, by Type, 2024-2033

8.1.1 Dietary Supplements

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Functional Beverages

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Functional Food

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Personal Care

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. U.S. Nutraceuticals Market, By Form

9.1. U.S. Nutraceuticals Market Revenue and Volume, by Form, 2024-2033

9.1.1. Capsules

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Liquid & Gummies

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Tablets & Soft Gels

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

9.1.4. Powder

9.1.4.1. Market Revenue and Volume Forecast (2021-2033)

9.1.5. Others

9.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. U.S. Nutraceuticals Market, By Sales Channel 

10.1. U.S. Nutraceuticals Market Revenue and Volume, by Sales Channel, 2024-2033

10.1.1. Offline

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Online Retail Stores

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. U.S. Nutraceuticals Market, Regional Estimates and Trend Forecast

11.1. U.S.

11.1.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.1.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.1.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

Chapter 12. Company Profiles

12.1. DSM

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Amway

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Pfizer Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Nestle

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Nature's Bounty

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. General Mills Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Danone

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. The Kraft Heinz Company

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. The Hain Celestial Group, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Tyson Foods

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms